Reaction
Coccydynia reporting signals
As of the last recalculation, Coccydynia appears in 1,448 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is INDOMETHACIN (PRR 19.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Indomethacin | 18 | 19.8 | 19.8 |
| Octreotide Acetate | 29 | 13.9 | 13.9 |
| Infliximab-Dyyb | 25 | 12.5 | 12.5 |
| Bicalutamide | 13 | 12.4 | 12.4 |
| Dorzolamide Hydrochloride And Timolol Maleate | 6 | 11.0 | 11.0 |
| Asfotase Alfa | 7 | 10.1 | 10.1 |
| Abaloparatide | 20 | 9.9 | 9.9 |
| Human Insulin | 7 | 8.1 | 8.1 |
| Acalabrutinib | 6 | 7.1 | 7.1 |
| Ado-Trastuzumab Emtansine | 4 | 6.8 | 6.8 |
| Agalsidase Beta | 4 | 6.2 | 6.2 |
| Regorafenib | 5 | 6.2 | 6.2 |
| Pertuzumab | 11 | 5.9 | 5.9 |
| Ocrelizumab | 24 | 5.6 | 5.6 |
| Teriparatide | 41 | 5.4 | 5.4 |
| Enzalutamide | 21 | 5.2 | 5.2 |
| Orlistat | 7 | 3.9 | 3.9 |
| Copper | 3 | 1.0 | 1.0 |